» Articles » PMID: 9745202

A Very High Level of Crossreactivity is an Essential Feature of the T-cell Receptor

Overview
Journal Immunol Today
Date 1998 Sep 24
PMID 9745202
Citations 340
Authors
Affiliations
Soon will be listed here.
Citing Articles

Developing T Cell Epitope-Based Vaccines Against Infection: Challenging but Worthwhile.

Tang X, Zhang W, Zhang Z Vaccines (Basel). 2025; 13(2).

PMID: 40006681 PMC: 11861332. DOI: 10.3390/vaccines13020135.


Mimicry-based strategy between human and commensal antigens for the development of a new family of immune therapies for cancer.

Talpin A, Maia A, Carpier J, Kulakowski G, Aubergeon L, Kervevan J J Immunother Cancer. 2025; 13(2).

PMID: 39979071 PMC: 11842988. DOI: 10.1136/jitc-2024-010192.


Molecular mimicry in the pathogenesis of autoimmune rheumatic diseases.

Fehringer M, Vogl T J Transl Autoimmun. 2025; 10:100269.

PMID: 39877080 PMC: 11773492. DOI: 10.1016/j.jtauto.2025.100269.


Dynamic allostery in the peptide/MHC complex enables TCR neoantigen selectivity.

Ma J, Ayres C, Brambley C, Chandran S, Rosales T, Perera W Nat Commun. 2025; 16(1):849.

PMID: 39833157 PMC: 11756396. DOI: 10.1038/s41467-025-56004-8.


Unveiling cross-reactivity: implications for immune response modulation in cancer.

Pretti M, Vieira G, Boroni M, Bonamino M Brief Bioinform. 2025; 26(1).

PMID: 39831892 PMC: 11744606. DOI: 10.1093/bib/bbaf012.